Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, July 2001, p. 2136-2140, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2136-2140.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Fluoroquinolone Resistance in Anaerobic Bacteria
following Exposure to Levofloxacin, Trovafloxacin, and Sparfloxacin
in an In Vitro Pharmacodynamic Model
Gigi H.
Ross,1,2
David H.
Wright,1,2
Laurie Baeker
Hovde,2
Marnie L.
Peterson,1,2 and
John C.
Rotschafer1,2,*
University of Minnesota, College of Pharmacy,
Minneapolis, Minnesota, 55455,1 and
Regions Hospital, Department of Clinical Pharmacy, St.
Paul, Minnesota, 551012
Received 24 February 2000/Returned for modification 4 July
2000/Accepted 18 April 2001
This investigation explored pharmacodynamic characteristics of
fluoroquinolones against Bacteroides thetaiotamicron and
the potential for development of resistance. An in vitro model was used
to generate kill curves with three fluoroquinolones at various area
under the concentration-time curve (AUC)/MIC ratios.
Concentration-independent killing was observed. Increases in MICs were
noted following exposure to fluoroquinolones at AUC/MIC ratios of 6 to 14.
*
Corresponding author. Mailing address: Department of
Clinical Pharmacy, Regions Hospital, 640 Jackson St., St. Paul, MN
55101. Phone: (651) 221-3896. Fax: (651) 292-4031. E-mail:
rotsc001{at}tc.umn.edu.
Antimicrobial Agents and Chemotherapy, July 2001, p. 2136-2140, Vol. 45, No. 7
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.7.2136-2140.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Noel, A. R., Bowker, K. E., MacGowan, A. P.
(2005). Pharmacodynamics of Moxifloxacin against Anaerobes Studied in an In Vitro Pharmacokinetic Model. Antimicrob. Agents Chemother.
49: 4234-4239
[Abstract]
[Full Text]
-
Zinner, S. H., Lubenko, I. Yu., Gilbert, D., Simmons, K., Zhao, X., Drlica, K., Firsov, A. A.
(2003). Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing. J Antimicrob Chemother
52: 616-622
[Abstract]
[Full Text]
-
Firsov, A. A., Vostrov, S. N., Lubenko, I. Y., Drlica, K., Portnoy, Y. A., Zinner, S. H.
(2003). In Vitro Pharmacodynamic Evaluation of the Mutant Selection Window Hypothesis Using Four Fluoroquinolones against Staphylococcus aureus. Antimicrob. Agents Chemother.
47: 1604-1613
[Abstract]
[Full Text]
-
Stein, G. E., Schooley, S., Tyrrell, K. L., Citron, D. M., Goldstein, E. J. C.
(2003). Bactericidal Activities of Methoxyfluoroquinolones Gatifloxacin and Moxifloxacin against Aerobic and Anaerobic Respiratory Pathogens in Serum. Antimicrob. Agents Chemother.
47: 1308-1312
[Abstract]
[Full Text]
-
Peterson, M. L., Hovde, L. B., Wright, D. H., Brown, G. H., Hoang, A. D., Rotschafer, J. C.
(2002). Pharmacodynamics of Trovafloxacin and Levofloxacin against Bacteroides fragilis in an In Vitro Pharmacodynamic Model. Antimicrob. Agents Chemother.
46: 203-210
[Abstract]
[Full Text]